Friday, April 26, 2024 4/26/2024

Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking well

Award Number: R01AI147321
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY Tuberculosis (TB) remains a leading cause of death globally, particularly among HIV-positive people. Understanding the dynamics of TB transmission in the era of antiretroviral therapy (ART) is key to halting TB transmission. As ART roll-out progresses, whether the contribution of people taking ART to TB transmission is increasing is unknown. Community TB surveys consistently show that about half of people with infectious TB do not report symptoms, and are therefore missed by most current TB screening efforts. The objective of this project is define how to target TB case-finding efforts to maximise impact while retaining cost-effectiveness, in settings of high HIV prevalence and mature ART programs. Our central hypothesis is that populations and settings can be defined where "symptom-agnostic" TB screening (i.e. not limited to symptomatic people) has a major impact on TB transmission, and is cost-effective. The project aims are (1) to compare the infectiousness of HIV-positive people taking ART compared to those not taking ART; (2) to assess the infectiousness of the "walking well", i.e. people with asymptomatic TB; (3) to model the impact and cost-effectiveness of symptom- agnostic screening at different levels of the health system. The project will be conducted in the context of the Africa Health Research Institute (AHRI)'s demographic surveillance area in KwaZulu-Natal, South Africa where TB incidence, HIV prevalence and ART coverage are high, and a population survey using mass radiographic screening for TB has started. We will accomplish our aims through a household contact study, measuring the proportion of child household contacts who have TB infection, comparing groups of households according to characteristics of the index TB patient. For Aim 1, we will compare the proportion of child contacts with TB infection between HIV-positive index TB patients who are vs. are not taking ART. For Aim 2, we will compare the proportion of child contacts with TB infection between asymptomatic index TB patients who do not report any symptoms (identified by AHRI's population TB survey) vs. symptomatic index TB patients. This gives us a unique opportunity to investigate TB transmission from people who do not report TB symptoms, who are missed by most TB screening programs. In Aim 3 we will use a novel mathematical model, incorporating new insights into TB natural history and transmission gained from Aims 1 and 2, to determine the circumstances under which symptom-agnostic screening would have most impact on TB incidence and mortality, and explore comparative cost-effectiveness of interventions along the diagnostic pathway at different levels of the health system. By combining population-based epidemiology with mathematical and economic modelling, our project will delineate (i) whether more resources should be dedicated to earlier identification of TB among people taking ART; (ii) whether symptom-agnostic screening of the "walking well"; should be considered and (iii) under what conditions. This could inform a paradigm shift in TB case-finding strategy.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $146,781 )
2023	2023	LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE	KEPPEL STREET	LONDON				GBR	Allergy and Infectious Diseases Research	001	5	8/30/2023	NON-COMPETING CONTINUATION	$146,780
2023	2023	LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE	KEPPEL STREET	LONDON				GBR	Allergy and Infectious Diseases Research	000	5	7/24/2023	NON-COMPETING CONTINUATION	$1
														Subtotal = $146,781

Issue Date FY: 2022 ( Subtotal = $462,515 )
2022	2022	LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE	KEPPEL ST	LONDON				GBR	Allergy and Infectious Diseases Research	000	4	8/31/2022	NON-COMPETING CONTINUATION	$462,515
														Subtotal = $462,515

Issue Date FY: 2021 ( Subtotal = $447,569 )
2021	2021	LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE	KEPPEL ST	LONDON				GBR	Allergy and Infectious Diseases Research	000	3	8/6/2021	NON-COMPETING CONTINUATION	$447,569
														Subtotal = $447,569

Issue Date FY: 2020 ( Subtotal = $499,031 )
2020	2020	LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE	KEPPEL ST	LONDON		WC1E 7HT		GBR	Allergy and Infectious Diseases Research	001	2	7/15/2020	NON-COMPETING CONTINUATION	$499,031
2020	2019	LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE	KEPPEL ST	LONDON		WC1E 7HT		GBR	Allergy and Infectious Diseases Research	000	1	6/11/2020	NEW	$0
														Subtotal = $499,031

Issue Date FY: 2019 ( Subtotal = $498,771 )
2019	2019	LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE	KEPPEL ST	LONDON		WC1E 7HT		GBR	Allergy and Infectious Diseases Research	000	1	8/1/2019	NEW	$498,771
														Subtotal = $498,771

Grand Total All Awards = $2,054,667

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking well

Award Number: R01AI147321

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer